IIJIMA MASAMI enters TAKEDA PHARMACEUTICAL CO LTD with 12.80K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0001395064-26-000058
Director
Since Mar 2026
12.80K
Baseline shares
100% direct
12.80K
Direct ownership
1 position
6.82K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares
DirectShares owned12.80K
Total
12.80K direct12.80K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 12.80K | Direct |
| Total | 12.80K | 12.80K direct |
Derivative Holdings3
Tax Obligation Award
DirectUnderlying security
Ordinary Shares
Underlying shares
2.28K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Tax Obligation Award
DirectUnderlying security
Ordinary Shares
Underlying shares
2.15K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Tax Obligation Award
DirectUnderlying security
Ordinary Shares
Underlying shares
2.39K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
6.82K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Tax Obligation Award Direct | Ordinary Shares | — | — | 2.28K | N/A | |
| Tax Obligation Award Direct | Ordinary Shares | — | — | 2.15K | N/A | |
| Tax Obligation Award Direct | Ordinary Shares | — | — | 2.39K | N/A | |
| Total | 6.82K | 0.00 | ||||